These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7065481)

  • 21. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
    Romero R; Kadar N; Gonzales Govea F; Hobbins JC
    Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic dosing method for oral theophylline in pediatric patients.
    Brocks DR; Lee KC; Tam YK; Weppler CP; Bradley JM
    Ther Drug Monit; 1988; 10(1):58-63. PubMed ID: 3376182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure.
    Jenne JW; Chick TW; Miller BA; Strickland RD
    Am J Hosp Pharm; 1977 Apr; 34(4):408-9. PubMed ID: 860722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualization of theophylline dosage using a single serum sample following a test dose.
    Shapiro GG; Koup JR; Furukawa CT; Pierson WE; Gibaldi M; Fuquay D; Bierman CW
    Pediatrics; 1982 Jan; 69(1):70-3. PubMed ID: 7054763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cimetidine on the pharmacokinetics of theophylline.
    Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
    Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis.
    Cobanoglu N; Atasoy H; Ozcelik U; Yalcin E; Dogru D; Kiper N; Gocmen A
    Pediatr Pulmonol; 2009 Jul; 44(7):706-12. PubMed ID: 19504563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adequacy of recommended aminophylline loading doses in children.
    Maxwell-Rubin M; Paap CM; Godley PJ
    Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tetracycline hydrochloride on theophylline kinetics.
    Mathis JW; Prince RA; Weinberger MM; McElnay JC
    Clin Pharm; 1982; 1(5):446-8. PubMed ID: 7184676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The disposition of theophylline in patients with lung and breast cancer.
    Corasaniti MT; Gatti G; Crema F; Attardo-Parrinello G; Barzaghi N; Perucca E
    Drugs Exp Clin Res; 1994; 20(3):115-20. PubMed ID: 7956718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two dosage schedules of sustained release theophylline in pediatric patients.
    Loren ML; Kirsten EB
    Ann Allergy; 1980 Apr; 44(4):200-3. PubMed ID: 7369552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal administration of theophylline in aqueous solution.
    Pedersen S; Sommer B
    Acta Paediatr Scand; 1981 Mar; 70(2):243-6. PubMed ID: 7234406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.